CClinicalTrials.gg
CompletedNCT00067769Updated Dec 7, 2015

Internet-based Treatment of Early Childhood Fecal Incontinence

An interventional study of Internet-based intervention UCanPoopToo and treatment as usual in Encopresis, sponsored by University of Virginia. Completed at 1 site in United States. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-12-07.

Sponsored by University of Virginia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
91
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

Encopresis, also known as fecal incontinence, is the voluntary or involuntary passage of stools causing soiling of clothes by a child over 4 years of age. The purpose of this study is to evaluate an Internet intervention for the treatment of encopresis.

Read the detailed description

An estimated 2.3% of children suffer from encopresis. Enhanced Toilet Training (ETT) is one of the most effective ways of treating this disorder. When delivered by skilled and knowledgeable clinicians, ETT is twice as effective as intensive medical management alone. Although ETT is effective in treating encopretic children, there are six major barriers to its implementation: 1) availability of a knowledgeable and skilled clinician; 2) parental acceptance of referral to a mental health professional; 3) expense of service; 4) burden of time and distance to access such specialty services; 5) child resistance to disclosure of embarrassing material; and 6) willingness of the child and parent to follow treatment recommendations. This project will circumvent these barriers by developing an interactive Internet-based ETT program. The study will then assess the feasibility of the program by determining the acceptance, function, and effectiveness of the intervention.

This project will have four phases. Phase 1 will identify optimal Internet and treatment elements as well as issues in need of experimental investigation. Phase 2 will investigate how to enhance Internet interventions. Phase 3 will evaluate the relative benefit of adding the Internet treatment to clinical services provided by clinicians in the fields of medicine and mental health. Phase 4 will investigate the relative long-term benefits of adding such an Internet-based intervention to professional care to determine its impact on symptom improvement, relapse prevention, quality of life, and its cost-effectiveness. Phase 4 will also assess to what extent the program is disseminated worldwide when made available on the Internet.

02

Conditions studied

  • Encopresis

Browse trials for

Keywords

  • Encopresis
  • Internet
  • Web
  • Treatment
  • Intervention
03

In context

Encopresis

34 studies on the registry are indexed under Encopresis; 12 are open to participants now.

This study's enrollment of 91 is above the median of 64 across 26 interventional studies indexed under Encopresis.

Browse Encopresis studies →

Lead sponsor

University of Virginia is the lead sponsor of 653 studies on the registry; 134 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 41 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Child seen by pediatrician, family physician, or psychologist for the treatment of encopresis
  • Access to the Internet, either through a family computer or a community computer

Exclusion criteria

Exclusion Criteria

  • Diagnosis of either mental retardation (IQ \< 85) or
  • A primary illness responsible for fecal soiling (e.g., spina bifida)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
91 participants (actual)

Study arms

  • Active comparator
    TAU

    Patients received treatment as usual (TAU) as defined as continued clinical care.

    Behavioral: treatment as usual

  • Experimental
    TAU+UCanPoopToo

    Patients received treatment as usual (TAU) plus the Internet intervention (UCanPoopToo.)

    Behavioral: Internet-based intervention UCanPoopToo

Interventions

  • BehavioralInternet-based intervention UCanPoopToo

    Internet-based intervention to administer Enhanced Toilet Training (ETT).

  • Behavioraltreatment as usual

    Routine clinical care.

06

What researchers measure

Primary outcomes

  1. Fecal accident outcomes with online diary data

    Number of accidents per 2 week period

    Time frame: Pre, Post (4-6 weeks), and one year Post after the intervention period (4-6 weeks)

  2. Success and cure rates

    Success rate as defined by having zero or one fecal accident over a two week period. Cure rate as defined by having zero accidents over the previous two weeks.

    Time frame: Post (4-6 weeks) and one year Post after the intervention period (4-6 weeks)

Secondary outcomes

  1. Fecal accident outcomes with retrospective data

    Number of accidents per 2 week period

    Time frame: Pre, Post (4-6 weeks), and one year Post after the intervention period (4-6 weeks)

  2. Parent knowledge of encopresis

    Parent knowledge of encopresis was assessed on a revised version of the Encopresis Knowledge Scale (EKS).

    Time frame: Pre, Post (4-6 weeks), and one year Post after the intervention period (4-6 weeks)

  3. Virginia Encopresis Constipation Apperception Test (VECAT)

    Parent assessment of child's bowel specific problems related to encopresis and constipation.

    Time frame: Pre, Post (4-6 weeks), and one year Post after the intervention period (4-6 weeks)

  4. Encopresis Cost Analysis

    Participants quantified items and events that occurred which contribute to the cost of encopresis such as number of diapers used, number of school days missed, number of parent trips to school, and clean-out procedures then cost estimates were applied to each.

    Time frame: Pre and Post (4-6 weeks)

Other outcomes

  1. Usage patterns of the Internet intervention

    Usage (number of Cores completed; number of Follow-ups completed and Modules assigned)

    Time frame: Post (4-6 weeks)

  2. Internet Intervention Utility Measure of Satisfaction

    Parent and child rated their satisfaction with the Internet intervention using the Internet Intervention Utility Questionnaire.

    Time frame: Post (4-6 weeks)

07

Study locations

1 site
  • University of Virginia Health System
    Charlottesville, Virginia 22902, United States
08

References and documents

Publications

  • Ritterband LM, Cox DJ, Walker LS, Kovatchev B, McKnight L, Patel K, Borowitz S, Sutphen J. An Internet intervention as adjunctive therapy for pediatric encopresis. J Consult Clin Psychol. 2003 Oct;71(5):910-7. doi: 10.1037/0022-006X.71.5.910. PubMed 14516239 ↗
  • Cox DJ, Morris JB Jr, Borowitz SM, Sutphen JL. Psychological differences between children with and without chronic encopresis. J Pediatr Psychol. 2002 Oct-Nov;27(7):585-91. doi: 10.1093/jpepsy/27.7.585. PubMed 12228330 ↗
  • Borowitz SM, Cox DJ, Sutphen JL, Kovatchev B. Treatment of childhood encopresis: a randomized trial comparing three treatment protocols. J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):378-84. doi: 10.1097/00005176-200204000-00012. PubMed 11930093 ↗
  • Brooks RC, Copen RM, Cox DJ, Morris J, Borowitz S, Sutphen J. Review of the treatment literature for encopresis, functional constipation, and stool-toileting refusal. Ann Behav Med. 2000 Summer;22(3):260-7. doi: 10.1007/BF02895121. PubMed 11211851 ↗
  • Borowitz SM, Cox DJ, Sutphen JL. Differences in toileting habits between children with chronic encopresis, asymptomatic siblings, and asymptomatic nonsiblings. J Dev Behav Pediatr. 1999 Jun;20(3):145-9. doi: 10.1097/00004703-199906000-00002. PubMed 10393070 ↗
  • Cox DJ, Sutphen J, Borowitz S, Kovatchev B, Ling W. Contribution of behavior therapy and biofeedback to laxative therapy in the treatment of pediatric encopresis. Ann Behav Med. 1998 Spring;20(2):70-6. doi: 10.1007/BF02884451. PubMed 9989311 ↗
  • Cox DJ, Sutphen J, Ling W, Quillian W, Borowitz S. Additive benefits of laxative, toilet training, and biofeedback therapies in the treatment of pediatric encopresis. J Pediatr Psychol. 1996 Oct;21(5):659-70. doi: 10.1093/jpepsy/21.5.659. PubMed 8936895 ↗
  • Ling W, Cox DJ, Sutphen J, Borowitz S. Psychological factors in encopresis: comparison of patients to nonsymptomatic siblings. Clin Pediatr (Phila). 1996 Aug;35(8):427. doi: 10.1177/000992289603500814. No abstract available. PubMed 8862907 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00067769
Lead sponsor
University of Virginia
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible party
Daniel Cox, PhD (Professor, Department of Psychiatry and NB Sciences, University of Virginia) — Principal investigator
First posted
Aug 28, 2003
Start date
Oct 2003
Primary completion
Jul 2007
Completion
Jul 2007
Last update
Dec 7, 2015

Study contacts

Daniel J Cox, PhD
principal investigator · University of Virginia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion